Agent Houlihan helps fund working capital, general corporate purposes
By Devika Patel
Knoxville, Tenn., March 7 - ThermoGenesis Corp. will conduct a registered direct offering of units, according to a prospectus supplement filed Monday with the Securities and Exchange Commission. The deal will raise $4.5 million through agent Houlihan Lokey Capital, Inc.
The company will sell 2.25 million units of one common share and a half-share warrant at $2.00 per unit. The whole warrants are exercisable at $2.64 for five years. The strike price is a 17.33% premium to the March 4 closing share price of $2.25.
Settlement is expected March 9.
Proceeds will be used for working capital and general corporate purposes.
Rancho Cordova, Calif.-based Thermogenesis develops and manufactures automated blood processing systems and disposables.
| Issuer: | ThermoGenesis Corp.
|
| Issue: | Units of one common share and a half-share warrant
|
| Amount: | $4.5 million
|
| Units: | 2.25 million
|
| Price: | $2.00
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $2.64
|
| Agent: | Houlihan Lokey Capital, Inc.
|
| Pricing date: | March 4
|
| Settlement date: | March 9
|
| Stock symbol: | Nasdaq: KOOL
|
| Stock price: | $2.25 at close March 4
|
| Market capitalization: | $31.58 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
